Business Description
Diagnos Inc
NAICS : 621999
SIC : 8639
ISIN : CA2524422078
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.77 | |||||
Equity-to-Asset | -0.32 | |||||
Debt-to-Equity | -3.55 | |||||
Debt-to-EBITDA | -1.23 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -24.14 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.6 | |||||
3-Year EBITDA Growth Rate | -4.3 | |||||
3-Year EPS without NRI Growth Rate | -10.1 | |||||
3-Year FCF Growth Rate | -10.9 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 19.86 | |||||
9-Day RSI | 36.42 | |||||
14-Day RSI | 42.4 | |||||
6-1 Month Momentum % | -8.2 | |||||
12-1 Month Momentum % | -28.21 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.09 | |||||
Quick Ratio | 1.09 | |||||
Cash Ratio | 1.03 | |||||
Days Sales Outstanding | 60.2 | |||||
Days Payable | 113.45 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.4 | |||||
Shareholder Yield % | -18.66 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -517.53 | |||||
Operating Margin % | -1803.9 | |||||
Net Margin % | -2178.57 | |||||
FCF Margin % | -1611.04 | |||||
ROA % | -261.82 | |||||
ROIC % | -204.08 | |||||
ROC (Joel Greenblatt) % | -1076.86 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 147.5 | |||||
EV-to-EBIT | -10.38 | |||||
EV-to-EBITDA | -10.89 | |||||
EV-to-Revenue | 186.92 | |||||
EV-to-Forward-Revenue | 87.13 | |||||
EV-to-FCF | -12.18 | |||||
Price-to-Median-PS-Value | 7.38 | |||||
Earnings Yield (Greenblatt) % | -9.64 | |||||
FCF Yield % | -8.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Diagnos Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.154 | ||
EPS (TTM) (C$) | -0.04 | ||
Beta | -0.38 | ||
Volatility % | 56.9 | ||
14-Day RSI | 42.4 | ||
14-Day ATR (C$) | 0.014327 | ||
20-Day SMA (C$) | 0.314 | ||
12-1 Month Momentum % | -28.21 | ||
52-Week Range (C$) | 0.23 - 0.43 | ||
Shares Outstanding (Mil) | 95 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Diagnos Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Diagnos Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Diagnos Inc Frequently Asked Questions
What is Diagnos Inc(TSXV:ADK)'s stock price today?
When is next earnings date of Diagnos Inc(TSXV:ADK)?
Does Diagnos Inc(TSXV:ADK) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |